Given all of the pitfalls we encounter in life such as automobile accidents, natural disasters, and wars, it would be remarkable if one could live significantly beyond the current lifespan even if aging were defeated completely. Nonetheless, most of us would relish the chance to live a few extra younger, more vital years. Asc2P may offer that chance!

During the last two decades of his life, Linus Pauling, winner of the Nobel Prize in Chemistry, advocated mega doses of ascorbic acid (vitamin C) to slow aging and other age related diseases. He was on the right track, but unfortunately for him, the right form of ascorbic acid did not exist at that time. Now it may.

Asc2P is the acronym for a special type of ascorbic acid, that is resistant to intercellular oxidation. In research by K. Furumoto and colleagues of the Department of Cell Biology at Hiroshima Prefectural University, Asc2P exhibited a positive effect on telomerase levels, and reduced telomere shortening and therefore cellular aging in vivo to 52% - 62%!

The international location of the Vida Institute in Costa Rica permits it to conduct a human trial of Asc2P to determine the effect that the slowing of cellular aging has on the aging of the human organism as a whole. Volunteers for the human trial are currently being accepted.

Human Trial of Asc2P

Participants in the human trial of Asc2P will be asked to fill out a short questionaire regarding the current state of their health, and then follow-up questionaires on a quarterly basis. There is a cost for participation, and there is a limit to the number of participants that will be accepted. If you are interested in participating, click on the button below. You will be directed to the initial online survey/application form. Upon completing this form, you will be taken to the order page for Asc2P.